Specific human endogenous retroviruses predict metastatic potential in uveal melanoma

Specific human endogenous retroviruses predict metastatic potential in uveal melanoma

Uveal melanoma (UM) is a unique disease in that patients with primary UM are well stratified based on their risk of developing metastasis, yet there are limited effective treatments once metastases occur. There is an urgent need to better understand the distinct molecular pathogenesis of UM and the...

Bibliografske podrobnosti
Main Authors:	Matthew L. Bendall, Jasmine H. Francis, Alexander N. Shoushtari, Douglas F. Nixon
Format:	Article
Jezik:	English
Izdano:	American Society for Clinical investigation 2022-05-01
Serija:	JCI Insight
Teme:	Microbiology Oncology
Online dostop:	https://doi.org/10.1172/jci.insight.147172

Podobne knjige/članki

Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
od: Angelo Limeta, et al.
Izdano: (2020-12-01)

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
od: Alexander Z. Wei, et al.
Izdano: (2022-09-01)

Multiregional genetic evolution of metastatic uveal melanoma
od: Daniel A. Rodriguez, et al.
Izdano: (2021-08-01)

Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors
od: Jasmine H. Francis, et al.
Izdano: (2024-06-01)

Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin
od: Jan Attig, et al.
Izdano: (2023-07-01)

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma
od: Shin Kobayashi, et al.
Izdano: (2023-08-01)

The Economic Value of MR-Imaging for Uveal Melanoma
od: Grech Fonk L, et al.
Izdano: (2020-04-01)

Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival
od: Allison R. Kolbe, et al.
Izdano: (2020-08-01)

Comprehensive analysis of chromosome 8 abnormalities and its prognostic value in patients with uveal melanoma
od: V. A. Yarovaya, et al.
Izdano: (2022-03-01)

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
od: Shaheer Khan, et al.
Izdano: (2022-09-01)

Prognostic fine needle aspiration biopsy of uveal melanoma: Molecular and genetic factors of metastasis risk
od: V. A. Yarovaya, et al.
Izdano: (2023-10-01)

Ribosomal profiling of human endogenous retroviruses in healthy tissues
od: Nicholas Dopkins, et al.
Izdano: (2024-01-01)

Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma
od: Yewlin E. Chee, et al.
Izdano: (2021-09-01)

Human endogenous retrovirus expression landscape in models of HIV-1 latency
od: M. de Mulder Rougvie, et al.
Izdano: (2019-07-01)

Human-Specific Endogenous Retroviruses
od: Anton Buzdin
Izdano: (2007-01-01)

Paleovirology of human endogenous retroviruses
od: Gifford, R, et al.
Izdano: (2009)

Paleovirology of human endogenous retroviruses
od: Gifford, R, et al.
Izdano: (2009)

Artificial intelligence in the diagnosis of uveal melanoma: advances and applications
od: Albert K. Dadzie, et al.
Izdano: (2025-02-01)

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
od: Jessica C Hassel, et al.
Izdano: (2024-06-01)

Editorial: Uveal melanoma: from lab bench to clinic – new therapeutic advances
od: Agata Grazia D'Amico, et al.
Izdano: (2023-06-01)

538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp
od: Joseph Sacco, et al.
Izdano: (2021-11-01)

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1
od: Maria Chiara Gelmi, MD, et al.
Izdano: (2023-09-01)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
od: Hakan Demirci, et al.
Izdano: (2013-01-01)

Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
od: Jie Yin, et al.
Izdano: (2023-04-01)

Tebentafusp: T cell redirection for the treatment of metastatic uveal melanoma
od: Damato, BE, et al.
Izdano: (2019)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
od: B. I. Dolgushin, et al.
Izdano: (2016-09-01)

The role of PET/CT in the diagnosis of metastatic uveal melanoma
od: S. V. Saakyan, et al.
Izdano: (2018-10-01)

Darovasertib, a novel treatment for metastatic uveal melanoma
od: Lei Cao, et al.
Izdano: (2023-07-01)

Molecular profiling of driver events in metastatic uveal melanoma
od: Joakim Karlsson, et al.
Izdano: (2020-04-01)

Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target
od: Gislaine Curty, et al.
Izdano: (2020-07-01)

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
od: Arun Singh, et al.
Izdano: (2020-05-01)

SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements
od: Jez L. Marston, et al.
Izdano: (2021-12-01)

Tumor microenvironment (TME) features and serum cytokines in patients with metastatic uveal and cutaneous melanoma treated with tebentafusp
od: O. Hamid, et al.
Izdano: (2024-01-01)

Polypeptide analysis of a porcine C-type retrovirus
od: Hamdan, Hasnah, et al.
Izdano: (1981)

Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
od: Sarah Howlett, et al.
Izdano: (2023-03-01)

Uveal Melanoma
od: Vasilios P. Papastefanou, et al.
Izdano: (2011-01-01)

The discovery of endogenous retroviruses
od: Weiss Robin A
Izdano: (2006-10-01)

Cerebellum-specific and age-dependent expression of an endogenous retrovirus with intact coding potential
od: Itoh Takayuki, et al.
Izdano: (2011-10-01)

Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma
od: Lisa Klaassen, et al.
Izdano: (2022-10-01)

Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
od: Sanjay Chandrasekhar, et al.
Izdano: (2024-04-01)